Barbara Ewals: Tony Hunter has been named the 2024 Prince Mahidol Award Laureate in Medicine
Barbara Ewals, CEO of SIOG (International Society of Geriatric Oncology), shared a post on LinkedIn:
“So thrilled to learn that Prof. Tony Hunter, from the Salk Institute for Biological Studies has been named the 2024 Prince Mahidol Award Laureate in Medicine.
His pioneering research on the tyrosine kinase enzyme and the phosphorylation process has transformed our understanding of cellular mechanisms, leading to groundbreaking advancements in cancer therapy.
Prof. Hunter’s discovery paved the way for the development of targeted cancer treatments by inhibiting tyrosine kinase enzymes, resulting in 86 tyrosine kinase inhibitors being approved, including the life-saving Imatinib (Gleevec) for leukemia.
With a legacy of innovation, Prof. Hunter joins the ranks of an esteemed group – 96 Prince Mahidol Award laureates, six of whom went on to win the Nobel Prize after.”
More posts featuring Barbara Ewals.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023